Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Can-Fite BioPharma Ltd (CANF)

:CANF

US Market

CANF

Can-Fite BioPharma

Analyst Forecasts

News & Insights

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding CANF?

Track your performance easily

Can-Fite BioPharma (CANF) Stock News & Sentiment

550 Followers

Can-Fite’s Namodenoson to be Highlighted for Liver Protection at ASCO Symposium

Company Announcements

Can-Fite’s Namodenoson to be Highlighted for Liver Protection at ASCO Symposium

23d ago

Can-Fite BioPharma’s Namodenoson Shows Promising Cancer Results

Company Announcements

Can-Fite BioPharma’s Namodenoson Shows Promising Cancer Results

2M ago

CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

Can-Fite BioPharma Advances in Pancreatic Cancer Trial

Company Announcements

Can-Fite BioPharma Advances in Pancreatic Cancer Trial

2M ago

Can-Fite BioPharma Secures Australian Patent for Obesity Drug

Company Announcements

Can-Fite BioPharma Secures Australian Patent for Obesity Drug

3M ago

Can-Fite BioPharma Secures Lucrative Deal with Vetbiolix

Company Announcements

Can-Fite BioPharma Secures Lucrative Deal with Vetbiolix

3M ago

Can-Fite’s Namodenoson Gains FDA Orphan Status

Company Announcements

Can-Fite’s Namodenoson Gains FDA Orphan Status

4M ago

More CANF News >

CANF News on the Web

2025-01-09

CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know

Zacks

Bullish

2024-12-31

D. Boral says Can-Fite's namodenoson may represent liver cancer 'paradigm shift'

The Fly

Neutral

2024-12-09

Bears are Losing Control Over CanFite Biopharma (CANF), Here's Why It's a 'Buy' Now

Zacks

Neutral

2024-11-05

Can-Fite BioPharma Secures Australian Patent for Obesity Drug

Yahoo Finance

Neutral

2024-10-18

Can-Fite BioPharma Secures Lucrative Deal with Vetbiolix

TipRanks News

Neutral

2024-10-18

Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson

Yahoo Finance

Neutral

2024-10-09

FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer

Yahoo Finance

Neutral

2024-10-07

Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on October 29

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

CANF

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week100%

Sector Average63%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CANF’s Media Buzz Sentiment?

Currently, no data Available

What is CANF’s weekly average amount of articles?

Currently, no data Available

What is CANF’s News Sentiment?

100% of articles about CANF were positive this week, compared to its sector average of 63%.

Healthcare Stocks that are Trending in the News

IRONDisc Medicine

ERASErasca

ANSLFAnsell

RVMDRevolution Medicines

RIGLRigel

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing